NYSE American suspends AtlasClear trading, starts delisting over low share price; ATCH to OTC

AtlasClear Holdings, Inc.

• NYSE American suspended trading in AtlasClear (ATCH) on Nov 10, 2026 and began delisting proceedings under Section 1003(f)(v) over the stock's low selling price.
• AtlasClear intends to appeal to a Listing Qualifications Panel and may pursue a reverse stock split; shares are expected to quote on the OTC Pink Limited Market under ATCH from Nov 11, 2026.
• AtlasClearing remains compliant with regulatory net capital requirements and has signed eight correspondent broker-dealer agreements; onboarding continues.
• Company cites fiscal 2026 revenue up 85% to $20.1 million and cash more than doubled to $15.4 million, without an at-the-market offering or equity line.
• Exchange said the delisting determination is based solely on the low selling price, not operations, regulatory capital or financial condition; shares remain outstanding.